Bile acid preparation and comprehensive analysis by high performance liquid chromatography–high-resolution mass spectrometry

Clinica Chimica Acta

Volumn 464, Issue , 2017, Pages 85-92

  Amplatz, Benno ^a   Zöhrer, Evelyn ^a   Haas, Christina ^a   Schäffer, Maria ^a   Stojakovic, Tatjana ^a   Jahnel, Jörg ^a   Fauler, Günter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bile acids; High performance liquid chromatography; High resolution mass spectrometry; Muricholic acids; Neonates

Indexed keywords

BILE ACID; CHEMICAL COMPOUND; PENTAFLUOROPHENYL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; URINALYSIS; VALIDATION PROCESS; ADOLESCENT; ADULT; ANALYSIS; BLOOD; CHILD; CLINICAL CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; ISOLATION AND PURIFICATION; NEWBORN; PROCEDURES; REPRODUCIBILITY; STANDARD; URINE;

ADOLESCENT; ADULT; ANALYTIC SAMPLE PREPARATION METHODS; BILE ACIDS AND SALTS; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLINICAL CHEMISTRY TESTS; HUMANS; INFANT, NEWBORN; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84995810515     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.11.014     Document Type: Article

References (25)

1. [1] Carey, M.C., Small, D.M., Micelle formation by bile salts. Physical-chemical and thermodynamic considerations. Arch. Intern. Med., 130, 1972, 506.
2. [2] Chiang, J.Y., Kimmel, R., Weinberger, C., Stroup, D., Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem., 275, 2000, 10918.
3. [3] Tu, H., Okamoto, A.Y., Shan, B., FXR, a bile acid receptor and biological sensor. Trends Cardiovasc. Med., 10, 2000, 30.
4. [4] Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., Pellicciari, R., Auwerx, J., Schoonjans, K., TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab., 10, 2009, 167.
5. [5] Beuers, U., Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol., 3, 2006, 318.
6. [6] Fisher, M.M., Magnusson, R., Miyai, K., Bile acid metabolism in mammals. I. Bile acid-induced intrahepatic cholestasis. Lab. Investig., 25, 1971, 88.
7. [7] Steiner, C., Othman, A., Saely, C.H., Rein, P., Drexel, H., von Eckardstein, A., Rentsch, K.M., Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus. PLoS One, 6, 2011, e25006.
8. [8] Staels, B., Handelsman, Y., Fonseca, V., Bile acid sequestrants for lipid and glucose control. Curr. Diab. Rep., 10, 2010, 70.
9. [9] Vincent, R.P., Omar, S., Ghozlan, S., Taylor, D.R., Cross, G., Sherwood, R.A., Fandriks, L., Olbers, T., Werling, M., Alaghband-Zadeh, J., le Roux, C.W., Higher circulating bile acid concentrations in obese patients with type 2 diabetes. Ann. Clin. Biochem., 50, 2013, 360.
10. [10] Van Erpecum, K.J., Portincasa, P., Eckhardt, E., Go, P.M., VanBerge-Henegouwen, G.P., Groen, A.K., Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile. Gastroenterology, 110, 1996, 1225.
11. [11] Stojakovic, T., Claudel, T., Putz-Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Sourij, H., Stauber, R.E., Winkler, K., Marz, W., Wascher, T.C., Trauner, M., Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. Atherosclerosis, 209, 2010, 178.
12. [12] Stojakovic, T., Putz-Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Stadlbauer, V., Gurakuqi, G., Stauber, R.E., Marz, W., Trauner, M., Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology, 46, 2007, 776.
13. [13] Griffiths, W.J., Sjovall, J., Bile acids: analysis in biological fluids and tissues. J. Lipid Res., 51, 2010, 23.
14. [14] Jantti, S.E., Kivilompolo, M., Ohrnberg, L., Pietilainen, K.H., Nygren, H., Oresic, M., Hyotylainen, T., Quantitative profiling of bile acids in blood, adipose tissue, intestine, and gall bladder samples using ultra high performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem., 406, 2014, 7799.
15. [15] Bobeldijk, I., Hekman, M., de Vries-van der Weij, J., Coulier, L., Ramaker, R., Kleemann, R., Kooistra, T., Rubingh, C., Freidig, A., Verheij, E., Quantitative profiling of bile acids in biofluids and tissues based on accurate mass high resolution LC-FT-MS: compound class targeting in a metabolomics workflow. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 871, 2008, 306.
16. [16] Sarafian, M.H., Lewis, M.R., Pechlivanis, A., Ralphs, S., McPhail, M.J., Patel, V.C., Dumas, M.E., Holmes, E., Nicholson, J.K., Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry. Anal. Chem., 87, 2015, 9662.
17. [17] Mills, K.A., Mushtaq, I., Johnson, A.W., Whitfield, P.D., Clayton, P.T., A method for the quantitation of conjugated bile acids in dried blood spots using electrospray ionization-mass spectrometry. Pediatr. Res., 43, 1998, 361.
18. [18] Li, J., Sha, Y., A convenient synthesis of amino acid methyl esters. Molecules, 13, 2008, 1111.
19. [19] Humbert, L., Maubert, M.A., Wolf, C., Duboc, H., Mahe, M., Farabos, D., Seksik, P., Mallet, J.M., Trugnan, G., Masliah, J., Rainteau, D., Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 899, 2012, 135.
20. [20] Graef, V., Furuya, E., Nishikaze, O., Hydrolysis of steroid glucuronides with beta-glucuronidase preparations from bovine liver, Helix pomatia, and E. coli. Clin. Chem., 23, 1977, 532.
21. [21] Roy, S., Slaunwhite, W.R. Jr., Metabolic effects of commercial beta-glucuronidase preparations on estrogens. Steroids, 16, 1970, 69.
22. [22] Huijghebaert, S., Parmentier, G., Eyssen, H., Specificity of bile salt sulfatase activity in man, mouse and rat intestinal microflora. J. Steroid Biochem., 20, 1984, 907.
23. [23] Jahnel, J., Zohrer, E., Scharnagl, H., Erwa, W., Fauler, G., Stojakovic, T., Reference ranges of serum bile acids in children and adolescents. Clin. Chem. Lab. Med., 2015.
24. [24] Tagliacozzi, D., Mozzi, A.F., Casetta, B., Bertucci, P., Bernardini, S., Di Ilio, C., Urbani, A., Federici, G., Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin. Chem. Lab. Med., 41, 2003, 1633.
25. [25] Jahnel, J., Zohrer, E., Alisi, A., Ferrari, F., Ceccarelli, S., De Vito, R., Scharnagl, H., Stojakovic, T., Fauler, G., Trauner, M., Nobili, V., Serum bile acid levels in children with nonalcoholic fatty liver disease. J. Pediatr. Gastroenterol. Nutr., 61, 2015, 85.